These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4367253)

  • 41. Nitroglycerin revisited: chemistry, biochemistry, interactions.
    di Carlo FJ
    Drug Metab Rev; 1975; 4(1):1-38. PubMed ID: 812687
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacokinetics in clinical practice. I. Concepts.
    Gibaldi M; Levy G
    JAMA; 1976 Apr; 235(17):1864-7. PubMed ID: 946488
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Macromolecule adducts, target dose and risk assessment.
    Ehrenberg L; Osterman-Golkar S; Törnqvist M
    Prog Clin Biol Res; 1986; 209B():253-60. PubMed ID: 3749083
    [No Abstract]   [Full Text] [Related]  

  • 44. [Practical problems of pharmacokinetics].
    Berkhin EB
    Klin Med (Mosk); 1984 Nov; 62(11):11-7. PubMed ID: 6521365
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effects of carcinogens and mutagens on nucleic acids. V. On the interaction of DNA with sarcolysin].
    Kushner VP; Khodosova IA
    Tsitologiia; 1968 Oct; 10(10):1313-8. PubMed ID: 5733949
    [No Abstract]   [Full Text] [Related]  

  • 46. [Fundamentals of drug metabolism].
    Netter KJ
    Arzneimittelforschung; 1972 Feb; 22(2):285-92. PubMed ID: 4402072
    [No Abstract]   [Full Text] [Related]  

  • 47. Partitioning phenomena in dosage form and biopharmaceutical design. 3. Some partitioning considerations in drug absorption, distribution, response and elimination.
    Schumacher GE
    Am J Hosp Pharm; 1972 Apr; 29(4):339-43. PubMed ID: 5025265
    [No Abstract]   [Full Text] [Related]  

  • 48. [Pharmacokinetics and compartmental analysis].
    Grégoire F
    J Pharm Belg; 1972; 27(5):631-47. PubMed ID: 4660651
    [No Abstract]   [Full Text] [Related]  

  • 49. [Some fundamental concepts of pharmacokinetic practice].
    Perrier CV; Griessen M
    Pharm Acta Helv; 1974; 49(7-8):217-28. PubMed ID: 4462123
    [No Abstract]   [Full Text] [Related]  

  • 50. Cytochrome P-448 and the activation of toxic chemicals and carcinogens.
    Ioannides C; Lum PY; Parke DV
    Xenobiotica; 1984; 14(1-2):119-37. PubMed ID: 6719936
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intra- and extra-cellular formation of metabolites from chemically reactive species.
    Gillette JR; Lau SS; Monks TJ
    Biochem Soc Trans; 1984 Feb; 12(1):4-7. PubMed ID: 6705984
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical importance of pharmacokinetic and pharmacodynamic drug interactions.
    Koch-Weser J
    Neth J Med; 1977; 20(2):59-70. PubMed ID: 325426
    [No Abstract]   [Full Text] [Related]  

  • 53. Mutagenicity and carcinogenicity of mycotoxins: DNA binding as a possible mode of action.
    Stark AA
    Annu Rev Microbiol; 1980; 34():235-62. PubMed ID: 7002024
    [No Abstract]   [Full Text] [Related]  

  • 54. Carcinogen-metabolizing enzymes and susceptibility to chemical carcinogenesis.
    Bartsch H; Aitio A; Camus AM; Malaveille C; Roberfroid M; Vo Thi KO; Sabadie N
    IARC Sci Publ; 1983; (51):147-56. PubMed ID: 6321342
    [No Abstract]   [Full Text] [Related]  

  • 55. Extramicrosomal drug metabolism.
    Pütter J
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):1-7. PubMed ID: 381004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug distribution and effect.
    Curry SH
    J R Coll Physicians Lond; 1970 Jul; 4(4):315-34. PubMed ID: 4948351
    [No Abstract]   [Full Text] [Related]  

  • 57. The problem of chemically reactive metabolites.
    Gillette JR
    Drug Metab Rev; 1982; 13(6):941-61. PubMed ID: 6754318
    [No Abstract]   [Full Text] [Related]  

  • 58. Toxic effects of chemicals: difficulties in extrapolating data from animals to man.
    Garattini S
    Crit Rev Toxicol; 1985; 16(1):1-29. PubMed ID: 3910353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Letter: Renal contribution to drug biotransformation.
    Kamath BL; Levy G
    J Pharm Sci; 1974 Aug; 63(8):1342-3. PubMed ID: 4852916
    [No Abstract]   [Full Text] [Related]  

  • 60. Domestication of chemistry by design of safer chemicals: structure-activity relationships.
    Ariëns EJ
    Drug Metab Rev; 1984; 15(3):425-504. PubMed ID: 6386409
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.